Pharma Faces: Bae Byoungjun, KoNECT, Korea
With over 30 years of experience in public office working in public health and pharmaceutical policy, food and drug safety regulations, national health and welfare policy, and overseas missions as…
Address: 15F, Haesung-2-building, Teheran-Ro 508, Gangnam-gu ,Seoul, Republic of Korea 135-725
Tel: +82-2-2185-3800
Web: http://www.merck.co.kr/en/index.html;jsessionid=BD027DF767B36C40BA9C1C74E6E903E9
Merck Republic of Korea, a Republic of Korean subsidiary of Merck KGaA Germany, a global research-driven pharmaceutical company dedicated to putting patients first; Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. Merck Republic of Korea Ltd. was founded in 1989 and established Merck Advanced Technologies Ltd. (MAT) in 2002 to better serve the Republic of Korean display industry. In the same year, an R&D and production center for liquid crystals and a warehouse were opened in Poseung.Earlier in 2009, Merck announced it is investing 14 billion Republic of Korean Won (? 11 million) to establish an Advanced Technology Center in Republic of Korea to improve it’s R&D and manufacturing capacities.
With over 30 years of experience in public office working in public health and pharmaceutical policy, food and drug safety regulations, national health and welfare policy, and overseas missions as…
Dr Bae Byuongjun, president of the Korea National Enterprise for Clinical Trials (KoNECT), outlines why Korea stands out in the APAC region as a top clinical trial destination, how clinical…
Founder, CEO and CTO Dr Chae-Ok Yun introduces GeneMedicine, a pioneer of the oncolytic virus approach in gene therapy. Dr Yun outlines the significance of a recent capital injection, ongoing…
South Korea is the 12th largest healthcare market globally with a market size of around USD 20 billion in 2019. With the government’s plans to invest over USD 1.7 billion…
Multinational pharma company managers working abroad must adapt to new cultures and develop a deep understanding of local markets. Korea is no different; here three foreign country managers give their…
Industry players – from Big Pharma giants to small local startups – are bringing new, innovative solutions to market in Korea in order to try and solve the country’s diabetes…
The nation of South Korea has overtaken many of its regional counterparts to boast a highly impressive biosimilars pipeline. Here, key stakeholders in Korean biologics and biosimilars explain how. …
ISU Abxis is a biotech company founded in 2001 with a focus on orphan drugs and rare disease. Part of the ISU chaebol, ISU Abxis has leveraged its parent company’s…
CEO of the Life Science division of LG – one of Korea most recognized global brands – Dr Jeewoong Son has spent much of his career gathering the knowhow to…
One of the indisputable economic success stories of the last half-century, South Korea now stands as the world’s 11th largest economy, with a reputation for industrial excellence and innovation. As…
The Korean cosmetics market is now the 8th largest in the world, with 2.9 percent of the global market share, capitalising on the global rise in interest for Korean culture,…
SK Plasma is a blood plasma company that was spun off from SK Chemicals in 2015. Its CEO, Yun Ho Kim, offers his insights into the company’s vision to establish…
See our Cookie Privacy Policy Here
